Pyxis Oncology Inc. (PYXS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pyxis Oncology Inc.

    NASDAQ: PYXS · Real-Time Price · USD
    1.33
    0.05 (3.91%)
    At close: Sep 02, 2025, 3:59 PM
    1.31
    -1.50%
    After-hours: Sep 02, 2025, 07:32 PM EDT

    Pyxis Oncology Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.18 -0.97 -0.38 -4.34
    PEG Ratio
    		 0.04 0.02 -0.01 -0.01
    PS Ratio
    		 5.65 n/a n/a n/a
    PB Ratio
    		 0.76 0.57 0.28 1.35
    P/FCF Ratio
    		 -1.57 -0.93 -0.46 -9.86
    P/OCF Ratio
    		 -1.58 -1.02 -0.5 -10.01
    OCF/S Ratio
    		 -3.57 n/a n/a n/a
    Debt / Equity Ratio
    		 0.17 0.17 0.12 0.00
    Quick Ratio
    		 7.49 4.84 5.87 14.90
    Current Ratio
    		 7.49 4.84 5.90 14.90
    Asset Turnover
    		 0.10 n/a n/a n/a
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.64 -0.59 -0.73 -0.31
    Return on Assets
    		 -0.49 -0.42 -0.56 -0.29
    Return on Invested Capital
    		 -0.61 -0.55 -0.67 -0.29
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.97 n/a n/a n/a
    Net Profit Margin
    		 -4.79 n/a n/a n/a
    Pretax Profit Margin
    		 -4.92 n/a n/a n/a
    Operating Profit Margin
    		 -5.54 n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -4.06 n/a n/a n/a

    Add to Watchlist